El cloramfenicol como inmunosupresor en el tratamiento del síndrome nefrótico del niño

Piantoni, Carlos; Atea, Jasinta; Suti, Raúl.
Arch. argent. pediatr ; 68(6): 191-203, 1970 Aug. tab
Artículo en Español | BINACIS, LILACS | ID: biblio-1159891

Documentos relacionados

  1. Practice variations in the management of childhood nephrotic syndrome in the Netherlands.
  2. Childhood nephrotic syndrome.
  3. Efficacy and safety of long-term repeated use of rituximab in pediatric patients with nephrotic syndrome.
  4. Quality of life in children with nephrotic syndrome: a cross-sectional study using Hindi version of PedsQL 4.0 Generic Core Scales.
  5. Efficacy and safety of rituximab for primary nephrotic syndrome with acute kidney injury: A two-center prospective cohort study.
  6. EFFICACY AND SAFETY OF CHLORAMPHENICOL TREATMENT FOR <i>BATRACHOCHYTRIUM DENDROBATIDIS</i> IN HELLBENDERS (<i>CRYPTOBRANCHUS ALLEGANIENSIS</i>).
  7. Response to steroid and immunosuppressive therapies may predict post-transplant recurrence of steroid-resistant nephrotic syndrome.
  8. Throwing off the keratin chains: a potential therapy for hereditary podocytopathy.
  9. Prophylactic rituximab administration in children with complicated nephrotic syndrome.
  10. Therapeutic trials in difficult to treat steroid sensitive nephrotic syndrome: challenges and future directions.